RxDoctor Payments Data

Karen Wood, MD

Family Medicine · Southport, NCNPI 1649340902

Payments from drug & device makers

$473in general payments, 2019–2025

Across 20 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$90
  • Amgen$71
  • Lilly USA, LLC$52
  • Pfizer$49
  • Heartflow, Inc.$48
  • Kedrion Biopharma, Inc.$21
  • plus $142 from 8 others

What the payments were for

  • Food & beverage$43993%
  • Education$357%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$473 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$154,744
Medicare patients
246
Services billed
1,612

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban35$39,877
TrulicityDulaglutide21$30,198
EliquisApixaban24$25,759
JanuviaSitagliptin Phosphate45$25,101
Repatha SureclickEvolocumab35$22,814
OzempicSemaglutide19$21,895
WegovySemaglutide14$19,351
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$9,460
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$9,448
Olmesartan Medoxomil208$4,765
Carvedilol ErCarvedilol Phosphate18$4,595
Rosuvastatin Calcium302$4,354
Atorvastatin Calcium337$3,502
Estradiol45$2,611
Duloxetine Hcl120$2,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$18$41,24633 claims
Lilly USA, LLCTrulicity$52$30,19821 claims
PfizerEliquis$49$25,75924 claims
GSKTrelegy Ellipta, Anoro Ellipta$90$18,90837 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Southport

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →